AKM Olmesartan Amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

akm olmesartan amlodipine 40/5 olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablets bottle pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: magnesium stearate; stearic acid; silicified microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olmesartan and amlodipine tablets are indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

OLMESARTAN/ AMLODIPINE HCT Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan/ amlodipine hct

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 13.888 mg/mg (equivalent: amlodipine, qty mg); hydrochlorothiazide, quantity: 25 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - olmesartan/ amlodipine hct - myl is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

OLMESARTAN/ AMLODIPINE HCT Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan/ amlodipine hct

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg) - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olmesartan/ amlodipine hct - myl is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

OLMESARTAN/ AMLODIPINE HCT Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan/ amlodipine hct

organon pharma pty ltd - olmesartan medoxomil, quantity: 20 mg; amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg); hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; croscarmellose sodium; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - olmesartan/ amlodipine hct - myl is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

OLMESARTAN/AMLODIPINE 40/5 APOTEX olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan/amlodipine 40/5 apotex olmesartan medoxomil 40 mg / amlodipine (as besilate) 5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; pregelatinised maize starch; silicified microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination (see dosage and administration).

OLMESARTAN/AMLODIPINE 20/5 APOTEX olmesartan medoxomil 20 mg / amlodipine (as besilate) 5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan/amlodipine 20/5 apotex olmesartan medoxomil 20 mg / amlodipine (as besilate) 5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 20 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; silicified microcrystalline cellulose; colloidal anhydrous silica; pregelatinised maize starch; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination (see dosage and administration).

OLMESARTAN/AMLODIPINE 40/10 APOTEX olmesartan medoxomil 40 mg / amlodipine (as besilate) 10 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan/amlodipine 40/10 apotex olmesartan medoxomil 40 mg / amlodipine (as besilate) 10 mg tablet blister pack

arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: silicified microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination (see dosage and administration).

OLMEKAR HCT 40/10/25 olmesartan medoxomi/amlodipine (as besilate) and hydrochlorothiazide 40 mg/10 mg/25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

olmekar hct 40/10/25 olmesartan medoxomi/amlodipine (as besilate) and hydrochlorothiazide 40 mg/10 mg/25 mg tablet blister pack

arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; titanium dioxide; iron oxide yellow; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination.this fixed dose combination is not indicated for initial therapy.

SEVIKAR HCT 40/5/12.5 olmesartan medoxomil 40 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sevikar hct 40/5/12.5 olmesartan medoxomil 40 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5 mg tablet blister pack

organon pharma pty ltd - amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg); olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: magnesium stearate; croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - sevikar hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

Olmesartan/Amlodipine Clonmel 20 mg/5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan/amlodipine clonmel 20 mg/5 mg film-coated tablets

clonmel healthcare ltd - olmesartan medoxomil; amlodipine besilate - film-coated tablet - 20 mg/5 milligram(s) - angiotensin ii antagonists and calcium channel blockers; olmesartan medoxomil and amlodipine